Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript

VRTX earnings call for the period ending June 30, 2023.

Related Keywords

United States ,Australia ,Canada ,American ,Geoff Meacham ,Colin Bristow ,Terence Flynn ,Liisa Bayko ,Terence Flynn Morgan Stanley ,David Risinger ,Salveen Richter ,Stuart Arbuckle ,Salveen Richter Goldman Sachs ,Robyn Karnauskas ,Phil Nadeau ,Susie Lisa ,Michael Yee Jefferies ,Michael Yee ,Phil Nadeau Cowen ,Robyn Karnauskas Truist ,Reshma Kewalramani ,Mohit Bansal ,Charlie Wagner ,Liisa Bayko Evercore ,David Risinger Leerink ,America Merrill Lynch ,Evan Seigerman ,Wells Fargo ,Geoff Meacham Bank ,Morgan Stanley ,Company Analyst ,Vertex Pharmaceuticals ,Goldman Sachs ,Exchange Commission ,American Diabetes Association Meeting ,Vice President ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Vanza Triple ,North America ,American Diabetes Association ,Fargo Securities ,Truist Securities ,Leerink Partners ,